TriSalus Life Sciences, Inc.
(TLSI)Financial Statements · SEC EDGAR XBRL
Revenue
$45.2M
+53.4%
Net Income
-$39.2M
-30.6%
EPS
$-1.84
-40.5%
Gross Margin
84.6%
Op. Income
-$26.9M
+25.5%
FCF
-$18.9M
+54.0%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Research & Development
Operating Income
Non-Operating Income/Expense
Interest Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)